A phase I dose-escalation study of the polyamine analog PG-11047 in patients with advanced solid tumors.
Saved in:
| Title: | A phase I dose-escalation study of the polyamine analog PG-11047 in patients with advanced solid tumors. |
|---|---|
| Authors: | Murray Stewart T; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, 1650 Orleans Street, CRB 1, Room 562, Baltimore, MD, 21287, USA. tmurray2@jhmi.edu., Desai AA; Illinois Cancer Specialists, Elgin, IL, 60123, USA., Fitzgerald ML; Apex, NC, 27502, USA., Marton LJ; Cancer Commons, Los Altos, CA, 94022, USA., Casero RA Jr; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, 1650 Orleans Street, CRB 1, Room 551, Baltimore, MD, 21287, USA. rcasero@jhmi.edu. |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2020 Jun; Vol. 85 (6), pp. 1089-1096. Date of Electronic Publication: 2020 May 23. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0843 |
|---|---|
| DOI: | 10.1007/s00280-020-04082-4 |
